Literature DB >> 14669071

A case of multiorgan failure following interruption of antiretroviral treatment.

M Crespo1, J C Paradiñeiro, E Ribera, I Ruiz, V Falcó, J Lopez-Quiñones, I Ocaña, A Pahissa.   

Abstract

Reported here is an exceptional case of acute retroviral syndrome resembling septic shock that occurred in a chronic HIV-infected patient shortly following planned interruption of antiretroviral treatment. The therapeutic strategy, which is aimed at improving the immunological control of HIV infection, can therefore be deleterious in chronically infected patients and should be avoided outside of closely monitored clinical trials.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14669071     DOI: 10.1007/s10096-003-1049-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  16 in total

Review 1.  HIV and direct damage of organs: disease spectrum before and during the highly active antiretroviral therapy era.

Authors:  Mauro Moroni; Spinello Antinori
Journal:  AIDS       Date:  2003-04       Impact factor: 4.177

Review 2.  Acute human immunodeficiency virus type 1 infection.

Authors:  J O Kahn; B D Walker
Journal:  N Engl J Med       Date:  1998-07-02       Impact factor: 91.245

3.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection.

Authors:  G Carcelain; R Tubiana; A Samri; V Calvez; C Delaugerre; H Agut; C Katlama; B Autran
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

6.  Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection.

Authors:  Simon D W Frost; Javier Martinez-Picado; Lidia Ruiz; Bonaventura Clotet; Andrew J Leigh Brown
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 7.  Structured treatment interruptions as a potential alternative therapeutic regimen for HIV-infected patients: a review of recent clinical data and future prospects.

Authors:  Franco Lori; Andrea Foli; Julianna Lisziewicz
Journal:  J Antimicrob Chemother       Date:  2002-08       Impact factor: 5.790

Review 8.  Lactic acidosis related to nucleoside therapy in HIV-infected patients.

Authors:  Vicenç Falcó; Manuel Crespo; Esteban Ribera
Journal:  Expert Opin Pharmacother       Date:  2003-08       Impact factor: 3.889

9.  Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy.

Authors:  Rochelle P Walensky; Sue J Goldie; Paul E Sax; Milton C Weinstein; A David Paltiel; April D Kimmel; George R Seage; Elena Losina; Hong Zhang; Runa Islam; Kenneth A Freedberg
Journal:  J Acquir Immune Defic Syndr       Date:  2002-09-01       Impact factor: 3.731

10.  Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults.

Authors:  Neil E Bowles; Jiyuan Ni; Debra L Kearney; Matthias Pauschinger; Heinz-Peter Schultheiss; Robert McCarthy; Joshua Hare; J Timothy Bricker; Karla R Bowles; Jeffrey A Towbin
Journal:  J Am Coll Cardiol       Date:  2003-08-06       Impact factor: 24.094

View more
  1 in total

1.  Novel Compound Inhibitors of HIV-1NL4-3 Vpu.

Authors:  Carolyn A Robinson; Terri D Lyddon; Hwi Min Gil; David T Evans; Yury V Kuzmichev; Jonathan Richard; Andrés Finzi; Sarah Welbourn; Lynn Rasmussen; N Miranda Nebane; Vandana V Gupta; Sam Ananthan; Zhaohui Cai; Elizabeth R Wonderlich; Corinne E Augelli-Szafran; Robert Bostwick; Roger G Ptak; Susan M Schader; Marc C Johnson
Journal:  Viruses       Date:  2022-04-15       Impact factor: 5.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.